Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly vs Weekly Risedronate with Vitamin D in Korean Postmenopausal Osteoporosis
NCT01904110Phase 4Completed
- Sponsor
- Hanlim Pharm
- Start
- Dec 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Risenex M in osteoporosis, sponsored by Hanlim Pharm. Started Dec 2012; status: completed.
02
Drugs
Risenex M
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01904110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904110.